Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Kawata

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of Medicinal Chemistry|December 9, 2014
RXR partial agonist produced by side chain repositioning of alkoxy RXR full agonist retains antitype 2 diabetes activity without the adverse effectsKohei Kawata, Ken-ichi Morishita, Mariko Nakayama, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full AgonistsHiroki Kakuta, Nobumasa Yakushiji, Ryosuke Shinozaki, et al.
Journal of Medicinal Chemistry|February 9, 2013
Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potencyFuminori Ohsawa, Shoya Yamada, Nobumasa Yakushiji, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of Medicinal Chemistry|December 9, 2014
RXR partial agonist produced by side chain repositioning of alkoxy RXR full agonist retains antitype 2 diabetes activity without the adverse effectsKohei Kawata, Ken-ichi Morishita, Mariko Nakayama, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full AgonistsHiroki Kakuta, Nobumasa Yakushiji, Ryosuke Shinozaki, et al.
Journal of Medicinal Chemistry|February 9, 2013
Mechanism of retinoid X receptor partial agonistic action of 1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1H-benzotriazole-5-carboxylic acid and structural development to increase potencyFuminori Ohsawa, Shoya Yamada, Nobumasa Yakushiji, et al.
Pageof 2